Search results
$295,041.50
- The estimated net worth of Aaron Kantoff is at least $295,041.50 as of October 24th, 2023. Mr. Kantoff owns 45,391 shares of Centessa Pharmaceuticals stock worth more than $295,042 as of November 27th.
www.insidertrades.com › centessa-pharmaceuticals-plc-american-depositary-shares-stock › aaron-kantoff
Sep 20, 2023 · The estimated net worth of Aaron Kantoff is at least $295,041.50 as of October 24th, 2023. Mr. Kantoff owns 45,391 shares of Centessa Pharmaceuticals stock worth more than $295,042 as of November 27th.
- 447.4B
- Director, Centessa Pharmaceuticals
- investorrelations@centessa.com
The estimated net worth of Aaron Kantoff is at least $2 Million dollars as of 2024-04-06. Aaron Kantoff is the Director of Tourmaline Bio Inc and owns about 45,391 shares of Tourmaline Bio Inc (TRML) stock worth over $1 Million .
Aaron Kantoff. Managing Partner. Aaron is a founder and Managing Partner of Scion. He has spent over a decade specializing in founding, building and investing in life sciences companies, focusing primarily on therapeutics.
Feb 7, 2024 · Aaron M. Kantoff. Aaron is a founder and Managing Partner of Scion. He has spent over a decade specializing in founding, building, and investing in life sciences companies, focusing primarily on therapeutics. Aaron currently serves as a board member of Tourmaline Bio (NASDAQ: TRML), where he has been serving since the company’s inception.
Jan 30, 2024 · Aaron Kantoff Director/Board Member at AVALO THERAPEUTICS, INC. Net worth: 28 M $ as of 2024-01-30
View Aaron Kantoff’s profile on LinkedIn, a professional community of 1 billion members.
- Scion Life Sciences
Feb 7, 2024 · Aaron Kantoff has an estimated net worth of $1.85 Million. This is based on reported shares across multiple companies, which include Centessa Pharmaceuticals plc, and Tourmaline Bio, Inc..
